Memory and Memory Impairment

Memory and Memory Impairment: The Increasing Role of Advanced Imaging Techniques

Thursday, Dec. 2, 3:00 – 4:00 PM

An expert panel is reviewing the clinical utility of biomarkers in diagnosis and drug development, discussing the evaluative role of FDG-PET and amyloid PET imaging and considering the role of advanced MR imaging in early identification of dementia, treatment monitoring and prediction of therapeutic response.

Speaker Information:
  • Jeffrey R. Petrella, MD, associate professor, radiology, Duke University Health System in Durham, N.C.;
  • R. Edward Coleman, MD, director, nuclear medicine, Duke University Health System in Durham, N.C.; and
  • P. Murali Doraiswamy, MD, associate professor, psychiatry, Duke University Health System in Durham, N.C.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.